MSCI Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MSCI Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $334.78M | Feb 26, 2018 |
| FY2017 | Sep 30, 2017 | $322.10M | Feb 26, 2018 |
| FY2017 | Jun 30, 2017 | $316.09M | Feb 26, 2018 |
| FY2017 | Mar 31, 2017 | $301.21M | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $292.81M | Feb 26, 2018 |
| FY2017 | Sep 30, 2016 | $288.43M | Feb 26, 2018 |
| FY2017 | Jun 30, 2016 | $290.60M | Feb 26, 2018 |
| FY2017 | Mar 31, 2016 | $278.83M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $272.89M | Feb 24, 2017 |
| FY2016 | Sep 30, 2015 | $268.77M | Feb 24, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.13B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $2.86B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $2.53B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $2.25B | Feb 7, 2025 |
| FY2021 | Dec 31, 2021 | $549.84M | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | $517.10M | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | $498.18M | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | $478.42M | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $443.66M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | $425.33M | Feb 11, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.20B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $1.11B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $1.15B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $870.57M | Feb 7, 2025 |
| FY2021 | Dec 31, 2021 | $193.87M | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | $169.88M | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | $165.42M | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | $196.82M | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $156.22M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | $182.36M | Feb 11, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $1.53B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $1.38B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $1.21B | Feb 7, 2025 |
| FY2021 | Dec 31, 2021 | $280.59M | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | $280.23M | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | $257.53M | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | $254.38M | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $234.09M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | $227.62M | Feb 11, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $177.60M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $158.65M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $132.12M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $107.21M | Feb 7, 2025 |
| FY2021 | Dec 31, 2021 | $30.82M | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | $28.35M | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | $27.53M | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | $24.86M | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | $27.06M | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | $24.90M | Feb 11, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $69.35M | Mar 2, 2015 |
| FY2014 | Sep 30, 2014 | $70.83M | Mar 2, 2015 |
| FY2014 | Jun 30, 2014 | $71.52M | Mar 2, 2015 |
| FY2014 | Mar 31, 2014 | $67.66M | Mar 2, 2015 |
| FY2014 | Dec 31, 2013 | $64.17M | Mar 2, 2015 |
| FY2014 | Sep 30, 2013 | $59.92M | Mar 2, 2015 |
| FY2014 | Jun 30, 2013 | $52.84M | Mar 2, 2015 |
| FY2014 | Mar 31, 2013 | $55.52M | Mar 2, 2015 |
| FY2013 | Dec 31, 2012 | $57.17M | Feb 28, 2014 |
| FY2013 | Sep 30, 2012 | $62.97M | Feb 28, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $1.50B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $1.24B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $936.07M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $811.11M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $709.52M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $612.76M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $404.16M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $442.36M | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.32M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $33.76M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $22.76M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $13.62M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $13.51M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $21.83M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $29.12M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $30.26M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $33.18M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $32.28M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.70B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $5.45B | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $5.52B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $5.00B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $5.51B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $4.20B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $4.20B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $3.39B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $3.28B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $3.08B | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.36B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $6.39B | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $6.26B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $6.01B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $5.67B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $4.64B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $4.28B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $3.55B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $2.87B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.76B | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.65B) | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | ($940.00M) | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | ($739.76M) | Feb 6, 2026 |
| FY2025 | Dec 31, 2022 | ($1.01B) | Feb 6, 2026 |
| FY2024 | Dec 31, 2021 | ($163.47M) | Feb 7, 2025 |
| FY2023 | Dec 31, 2020 | ($443.23M) | Feb 9, 2024 |
| FY2022 | Dec 31, 2019 | ($76.71M) | Feb 10, 2023 |
| FY2021 | Dec 31, 2018 | ($166.49M) | Feb 11, 2022 |
| FY2020 | Dec 31, 2017 | $401.01M | Feb 12, 2021 |
| FY2019 | Dec 31, 2016 | $317.61M | Feb 18, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.92B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $2.92B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $2.89B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $2.23B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $2.24B | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $1.57B | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $1.56B | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $1.55B | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $1.56B | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $1.56B | Feb 22, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.43B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $4.78B | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $4.18B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $3.47B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $2.98B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $2.55B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $2.20B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $1.86B | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $1.51B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.32B | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $515.33M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $409.35M | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $461.69M | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $993.56M | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $1.42B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $1.30B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $1.51B | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | $904.18M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | $889.50M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $791.83M | Feb 26, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.20B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $4.51B | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $4.51B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $4.51B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $4.16B | Feb 10, 2023 |
| FY2021 | Dec 31, 2020 | $3.37B | Feb 11, 2022 |
| FY2013 | Dec 31, 2013 | $810.00M | Feb 28, 2014 |
| FY2012 | Dec 31, 2012 | $858.00M | Mar 1, 2013 |
| FY2011 | Dec 31, 2011 | $1.08B | Feb 29, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 14 | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | 10 | Feb 7, 2025 |
| FY2021 | Dec 31, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | 1 | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | 2 | Feb 11, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 15 | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 14 | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | 10 | Feb 7, 2025 |
| FY2021 | Dec 31, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Sep 30, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Jun 30, 2021 | 1 | Feb 11, 2022 |
| FY2021 | Mar 31, 2021 | 2 | Feb 11, 2022 |
| FY2021 | Dec 31, 2020 | 1 | Feb 11, 2022 |
| FY2021 | Sep 30, 2020 | 2 | Feb 11, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 73.56M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 77.74M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 79.09M | Feb 6, 2026 |
| FY2025 | Dec 31, 2022 | 79.96M | Feb 6, 2026 |
| FY2024 | Dec 31, 2021 | 82.44M | Feb 7, 2025 |
| FY2021 | Dec 31, 2020 | 82.57M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 84.79M | Feb 12, 2021 |
| FY2019 | Dec 31, 2018 | 84.17M | Feb 18, 2020 |
| FY2018 | Dec 31, 2017 | 90.10M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 91.28M | Feb 26, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $556.52M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $509.11M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $440.99M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $372.92M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $302.45M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $246.44M | Feb 10, 2023 |
| FY2021 | Dec 31, 2019 | $222.92M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $170.94M | Feb 12, 2021 |
| FY2019 | Dec 31, 2017 | $119.72M | Feb 18, 2020 |
| FY2018 | Dec 31, 2016 | $96.19M | Feb 22, 2019 |